| UniProt ID | EP15R_HUMAN | |
|---|---|---|
| UniProt AC | Q9UBC2 | |
| Protein Name | Epidermal growth factor receptor substrate 15-like 1 | |
| Gene Name | EPS15L1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 864 | |
| Subcellular Localization |
Cell membrane Peripheral membrane protein. Nucleus. Membrane, coated pit. Localized to plasma membrane coated pits.. |
|
| Protein Description | Seems to be a constitutive component of clathrin-coated pits that is required for receptor-mediated endocytosis. Involved in endocytosis of integrin beta-1 (ITGB1) and transferrin receptor (TFR); internalization of ITGB1 as DAB2-dependent cargo but not TFR seems to require association with DAB2.. | |
| Protein Sequence | MAAPLIPLSQQIPTGNSLYESYYKQVDPAYTGRVGASEAALFLKKSGLSDIILGKIWDLADPEGKGFLDKQGFYVALRLVACAQSGHEVTLSNLNLSMPPPKFHDTSSPLMVTPPSAEAHWAVRVEEKAKFDGIFESLLPINGLLSGDKVKPVLMNSKLPLDVLGRVWDLSDIDKDGHLDRDEFAVAMHLVYRALEKEPVPSALPPSLIPPSKRKKTVFPGAVPVLPASPPPKDSLRSTPSHGSVSSLNSTGSLSPKHSLKQTQPTVNWVVPVADKMRFDEIFLKTDLDLDGYVSGQEVKEIFMHSGLTQNLLAHIWALADTRQTGKLSKDQFALAMYFIQQKVSKGIDPPQVLSPDMVPPSERGTPGPDSSGSLGSGEFTGVKELDDISQEIAQLQREKYSLEQDIREKEEAIRQKTSEVQELQNDLDRETSSLQELEAQKQDAQDRLDEMDQQKAKLRDMLSDVRQKCQDETQMISSLKTQIQSQESDLKSQEDDLNRAKSELNRLQQEETQLEQSIQAGRVQLETIIKSLKSTQDEINQARSKLSQLHESRQEAHRSLEQYDQVLDGAHGASLTDLANLSEGVSLAERGSFGAMDDPFKNKALLFSNNTQELHPDPFQTEDPFKSDPFKGADPFKGDPFQNDPFAEQQTTSTDPFGGDPFKESDPFRGSATDDFFKKQTKNDPFTSDPFTKNPSLPSKLDPFESSDPFSSSSVSSKGSDPFGTLDPFGSGSFNSAEGFADFSQMSKPPPSGPFTSSLGGAGFSDDPFKSKQDTPALPPKKPAPPRPKPPSGKSTPVSQLGSADFPEAPDPFQPLGADSGDPFQSKKGFGDPFSGKDPFVPSSAAKPSKASASGFADFTSVS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAPLIPLS ------CCCCCCCHH | 20.14 | 19413330 | |
| 9 | Phosphorylation | AAPLIPLSQQIPTGN CCCCCCHHHCCCCCC | 18.06 | 29083192 | |
| 14 | Phosphorylation | PLSQQIPTGNSLYES CHHHCCCCCCCHHHH | 51.10 | 28348404 | |
| 17 | Phosphorylation | QQIPTGNSLYESYYK HCCCCCCCHHHHHHC | 33.40 | 28348404 | |
| 19 | Phosphorylation | IPTGNSLYESYYKQV CCCCCCHHHHHHCCC | 11.58 | 28348404 | |
| 21 | Phosphorylation | TGNSLYESYYKQVDP CCCCHHHHHHCCCCH | 21.87 | 25627689 | |
| 22 | Phosphorylation | GNSLYESYYKQVDPA CCCHHHHHHCCCCHH | 11.62 | 25627689 | |
| 30 | Phosphorylation | YKQVDPAYTGRVGAS HCCCCHHHCCCCCHH | 18.34 | 25147952 | |
| 46 | Phosphorylation | AALFLKKSGLSDIIL HHHHHHHCCCCHHHH | 43.30 | 30266825 | |
| 46 (in isoform 2) | Phosphorylation | - | 43.30 | 27251275 | |
| 49 | Phosphorylation | FLKKSGLSDIILGKI HHHHCCCCHHHHHHH | 30.23 | 30266825 | |
| 49 (in isoform 2) | Phosphorylation | - | 30.23 | 27251275 | |
| 74 | Phosphorylation | FLDKQGFYVALRLVA CCCCCCHHHHHHHHH | 7.52 | 28152594 | |
| 90 | Phosphorylation | AQSGHEVTLSNLNLS HHCCCEEEEECCCCC | 22.83 | 26074081 | |
| 92 | Phosphorylation | SGHEVTLSNLNLSMP CCCEEEEECCCCCCC | 29.88 | 26074081 | |
| 97 | Phosphorylation | TLSNLNLSMPPPKFH EEECCCCCCCCCCCC | 28.33 | 26074081 | |
| 106 | Phosphorylation | PPPKFHDTSSPLMVT CCCCCCCCCCCEEEC | 23.64 | 22167270 | |
| 106 (in isoform 2) | Phosphorylation | - | 23.64 | 27251275 | |
| 107 | Phosphorylation | PPKFHDTSSPLMVTP CCCCCCCCCCEEECC | 35.70 | 22167270 | |
| 108 | Phosphorylation | PKFHDTSSPLMVTPP CCCCCCCCCEEECCC | 24.93 | 22167270 | |
| 108 (in isoform 2) | Phosphorylation | - | 24.93 | 27251275 | |
| 113 | Phosphorylation | TSSPLMVTPPSAEAH CCCCEEECCCCCHHE | 18.60 | 25159151 | |
| 113 (in isoform 2) | Phosphorylation | - | 18.60 | 27251275 | |
| 116 | Phosphorylation | PLMVTPPSAEAHWAV CEEECCCCCHHEEEE | 39.69 | 25159151 | |
| 146 | Phosphorylation | LPINGLLSGDKVKPV CCCCCCCCCCCCCCC | 50.41 | 25867546 | |
| 171 | Phosphorylation | LGRVWDLSDIDKDGH HHCCCCHHHCCCCCC | 30.01 | - | |
| 202 | Phosphorylation | LEKEPVPSALPPSLI HHHCCCCCCCCHHHC | 42.55 | 28509920 | |
| 207 | Phosphorylation | VPSALPPSLIPPSKR CCCCCCHHHCCCCCC | 36.67 | 28509920 | |
| 212 | Phosphorylation | PPSLIPPSKRKKTVF CHHHCCCCCCCCCCC | 39.47 | 28509920 | |
| 217 | Phosphorylation | PPSKRKKTVFPGAVP CCCCCCCCCCCCCEE | 30.34 | 23927012 | |
| 229 | Phosphorylation | AVPVLPASPPPKDSL CEEECCCCCCCCCCC | 35.68 | 29255136 | |
| 229 (in isoform 2) | Phosphorylation | - | 35.68 | 27251275 | |
| 235 | Phosphorylation | ASPPPKDSLRSTPSH CCCCCCCCCCCCCCC | 31.63 | 30278072 | |
| 238 | Phosphorylation | PPKDSLRSTPSHGSV CCCCCCCCCCCCCCC | 50.38 | 25159151 | |
| 239 | Phosphorylation | PKDSLRSTPSHGSVS CCCCCCCCCCCCCCC | 23.52 | 23927012 | |
| 241 | Phosphorylation | DSLRSTPSHGSVSSL CCCCCCCCCCCCCCC | 40.34 | 25159151 | |
| 241 (in isoform 2) | Phosphorylation | - | 40.34 | 27251275 | |
| 244 | Phosphorylation | RSTPSHGSVSSLNST CCCCCCCCCCCCCCC | 17.25 | 25159151 | |
| 244 (in isoform 2) | Phosphorylation | - | 17.25 | 27251275 | |
| 246 | Phosphorylation | TPSHGSVSSLNSTGS CCCCCCCCCCCCCCC | 30.70 | 23927012 | |
| 246 (in isoform 2) | Phosphorylation | - | 30.70 | 27251275 | |
| 247 | Phosphorylation | PSHGSVSSLNSTGSL CCCCCCCCCCCCCCC | 29.43 | 23927012 | |
| 247 (in isoform 2) | Phosphorylation | - | 29.43 | 27251275 | |
| 250 | Phosphorylation | GSVSSLNSTGSLSPK CCCCCCCCCCCCCCC | 39.16 | 25159151 | |
| 250 (in isoform 2) | Phosphorylation | - | 39.16 | 27251275 | |
| 251 | Phosphorylation | SVSSLNSTGSLSPKH CCCCCCCCCCCCCCC | 29.71 | 23927012 | |
| 253 | Phosphorylation | SSLNSTGSLSPKHSL CCCCCCCCCCCCCCC | 26.26 | 22167270 | |
| 253 (in isoform 2) | Phosphorylation | - | 26.26 | 27251275 | |
| 255 | Phosphorylation | LNSTGSLSPKHSLKQ CCCCCCCCCCCCCCC | 33.33 | 22167270 | |
| 255 (in isoform 2) | Phosphorylation | - | 33.33 | 27251275 | |
| 259 | Phosphorylation | GSLSPKHSLKQTQPT CCCCCCCCCCCCCCC | 43.31 | 23401153 | |
| 261 | Ubiquitination | LSPKHSLKQTQPTVN CCCCCCCCCCCCCEE | 55.07 | - | |
| 263 | Phosphorylation | PKHSLKQTQPTVNWV CCCCCCCCCCCEEEE | 34.62 | 28857561 | |
| 293 | Phosphorylation | TDLDLDGYVSGQEVK CCCCCCCCCCHHHHH | 7.36 | 25147952 | |
| 295 | Phosphorylation | LDLDGYVSGQEVKEI CCCCCCCCHHHHHHH | 26.69 | 27251275 | |
| 355 | Phosphorylation | IDPPQVLSPDMVPPS CCCCCCCCCCCCCCH | 21.72 | 25159151 | |
| 362 | Phosphorylation | SPDMVPPSERGTPGP CCCCCCCHHCCCCCC | 33.58 | 25159151 | |
| 362 (in isoform 2) | Phosphorylation | - | 33.58 | 27251275 | |
| 366 | Phosphorylation | VPPSERGTPGPDSSG CCCHHCCCCCCCCCC | 31.15 | 19664994 | |
| 366 (in isoform 2) | Phosphorylation | - | 31.15 | 27251275 | |
| 371 | Phosphorylation | RGTPGPDSSGSLGSG CCCCCCCCCCCCCCC | 39.47 | 29255136 | |
| 372 | Phosphorylation | GTPGPDSSGSLGSGE CCCCCCCCCCCCCCC | 39.52 | 29255136 | |
| 374 | Phosphorylation | PGPDSSGSLGSGEFT CCCCCCCCCCCCCCC | 31.35 | 29255136 | |
| 374 (in isoform 2) | Phosphorylation | - | 31.35 | 27251275 | |
| 377 | Phosphorylation | DSSGSLGSGEFTGVK CCCCCCCCCCCCCCC | 40.20 | 29255136 | |
| 377 (in isoform 2) | Phosphorylation | - | 40.20 | 27251275 | |
| 381 | Phosphorylation | SLGSGEFTGVKELDD CCCCCCCCCCCCHHH | 36.44 | 29255136 | |
| 384 | Ubiquitination | SGEFTGVKELDDISQ CCCCCCCCCHHHHHH | 54.63 | - | |
| 390 | Phosphorylation | VKELDDISQEIAQLQ CCCHHHHHHHHHHHH | 28.84 | 25159151 | |
| 390 (in isoform 2) | Phosphorylation | - | 28.84 | 27251275 | |
| 400 | Ubiquitination | IAQLQREKYSLEQDI HHHHHHHHHCHHHHH | 42.18 | - | |
| 401 | Phosphorylation | AQLQREKYSLEQDIR HHHHHHHHCHHHHHH | 17.46 | 29214152 | |
| 401 (in isoform 2) | Phosphorylation | - | 17.46 | 27642862 | |
| 402 | Phosphorylation | QLQREKYSLEQDIRE HHHHHHHCHHHHHHH | 36.18 | 25159151 | |
| 402 (in isoform 2) | Phosphorylation | - | 36.18 | 27251275 | |
| 417 | Ubiquitination | KEEAIRQKTSEVQEL HHHHHHHHHHHHHHH | 44.14 | - | |
| 418 | Phosphorylation | EEAIRQKTSEVQELQ HHHHHHHHHHHHHHH | 23.06 | - | |
| 432 | Phosphorylation | QNDLDRETSSLQELE HHHHHHHHHHHHHHH | 25.22 | 26657352 | |
| 433 | Phosphorylation | NDLDRETSSLQELEA HHHHHHHHHHHHHHH | 25.05 | 25850435 | |
| 434 | Phosphorylation | DLDRETSSLQELEAQ HHHHHHHHHHHHHHH | 41.30 | 25849741 | |
| 434 (in isoform 2) | Phosphorylation | - | 41.30 | 27251275 | |
| 462 | Sulfoxidation | QKAKLRDMLSDVRQK HHHHHHHHHHHHHHH | 2.89 | 21406390 | |
| 478 | Phosphorylation | QDETQMISSLKTQIQ HHHHHHHHHHHHHHH | 25.03 | 24719451 | |
| 482 | Phosphorylation | QMISSLKTQIQSQES HHHHHHHHHHHHHHH | 35.88 | 21601212 | |
| 486 | Phosphorylation | SLKTQIQSQESDLKS HHHHHHHHHHHHHHH | 37.23 | 25159151 | |
| 486 (in isoform 2) | Phosphorylation | - | 37.23 | 27251275 | |
| 489 | Phosphorylation | TQIQSQESDLKSQED HHHHHHHHHHHHHHH | 40.38 | 22817901 | |
| 492 | Ubiquitination | QSQESDLKSQEDDLN HHHHHHHHHHHHHHH | 55.90 | 21890473 | |
| 492 (in isoform 2) | Ubiquitination | - | 55.90 | - | |
| 518 | Phosphorylation | EETQLEQSIQAGRVQ HHHHHHHHHHHCCHH | 13.80 | 28555341 | |
| 528 | Phosphorylation | AGRVQLETIIKSLKS HCCHHHHHHHHHHHC | 36.27 | 20068231 | |
| 531 | Ubiquitination | VQLETIIKSLKSTQD HHHHHHHHHHHCCHH | 45.98 | 21890473 | |
| 531 | Ubiquitination | VQLETIIKSLKSTQD HHHHHHHHHHHCCHH | 45.98 | 21890473 | |
| 531 | Ubiquitination | VQLETIIKSLKSTQD HHHHHHHHHHHCCHH | 45.98 | 21890473 | |
| 531 | Ubiquitination | VQLETIIKSLKSTQD HHHHHHHHHHHCCHH | 45.98 | 21890473 | |
| 531 (in isoform 2) | Ubiquitination | - | 45.98 | - | |
| 534 | Ubiquitination | ETIIKSLKSTQDEIN HHHHHHHHCCHHHHH | 59.56 | 21906983 | |
| 534 (in isoform 2) | Ubiquitination | - | 59.56 | - | |
| 546 | Acetylation | EINQARSKLSQLHES HHHHHHHHHHHHHHH | 46.75 | 25953088 | |
| 546 | Ubiquitination | EINQARSKLSQLHES HHHHHHHHHHHHHHH | 46.75 | - | |
| 546 (in isoform 2) | Ubiquitination | - | 46.75 | - | |
| 548 | Phosphorylation | NQARSKLSQLHESRQ HHHHHHHHHHHHHHH | 34.14 | 29214152 | |
| 553 | Phosphorylation | KLSQLHESRQEAHRS HHHHHHHHHHHHHHH | 28.63 | 28555341 | |
| 560 | Phosphorylation | SRQEAHRSLEQYDQV HHHHHHHHHHHHHHH | 26.79 | 25159151 | |
| 560 (in isoform 2) | Phosphorylation | - | 26.79 | 27642862 | |
| 564 | Phosphorylation | AHRSLEQYDQVLDGA HHHHHHHHHHHHHHC | 10.04 | 28176443 | |
| 564 (in isoform 2) | Phosphorylation | - | 10.04 | 27642862 | |
| 575 | Phosphorylation | LDGAHGASLTDLANL HHHCCCCCHHHHHHH | 36.07 | 25159151 | |
| 575 (in isoform 2) | Phosphorylation | - | 36.07 | 27642862 | |
| 577 | Phosphorylation | GAHGASLTDLANLSE HCCCCCHHHHHHHHH | 26.86 | 25159151 | |
| 583 | Phosphorylation | LTDLANLSEGVSLAE HHHHHHHHHCCCHHH | 31.92 | 28450419 | |
| 583 (in isoform 2) | Phosphorylation | - | 31.92 | 27251275 | |
| 587 | Phosphorylation | ANLSEGVSLAERGSF HHHHHCCCHHHHCCC | 32.49 | 25627689 | |
| 593 | Phosphorylation | VSLAERGSFGAMDDP CCHHHHCCCCCCCCC | 27.08 | 23401153 | |
| 593 (in isoform 2) | Phosphorylation | - | 27.08 | 27251275 | |
| 593 (in isoform 4) | Phosphorylation | - | 27.08 | 27251275 | |
| 597 | Sulfoxidation | ERGSFGAMDDPFKNK HHCCCCCCCCCCCCC | 6.50 | 21406390 | |
| 602 | Ubiquitination | GAMDDPFKNKALLFS CCCCCCCCCCEEEEC | 64.03 | 21890473 | |
| 602 | Ubiquitination | GAMDDPFKNKALLFS CCCCCCCCCCEEEEC | 64.03 | 21890473 | |
| 602 | Ubiquitination | GAMDDPFKNKALLFS CCCCCCCCCCEEEEC | 64.03 | 21890473 | |
| 604 | Ubiquitination | MDDPFKNKALLFSNN CCCCCCCCEEEECCC | 40.79 | 21890473 | |
| 604 | Ubiquitination | MDDPFKNKALLFSNN CCCCCCCCEEEECCC | 40.79 | 21890473 | |
| 604 | Ubiquitination | MDDPFKNKALLFSNN CCCCCCCCEEEECCC | 40.79 | 21890473 | |
| 604 (in isoform 2) | Ubiquitination | - | 40.79 | - | |
| 609 | Phosphorylation | KNKALLFSNNTQELH CCCEEEECCCCCCCC | 29.19 | 26074081 | |
| 612 | Phosphorylation | ALLFSNNTQELHPDP EEEECCCCCCCCCCC | 27.89 | 22199227 | |
| 612 (in isoform 2) | Phosphorylation | - | 27.89 | 27251275 | |
| 627 | Ubiquitination | FQTEDPFKSDPFKGA CCCCCCCCCCCCCCC | 60.38 | 21890473 | |
| 627 (in isoform 2) | Ubiquitination | - | 60.38 | - | |
| 628 | Phosphorylation | QTEDPFKSDPFKGAD CCCCCCCCCCCCCCC | 51.39 | 25159151 | |
| 628 (in isoform 2) | Phosphorylation | - | 51.39 | 27251275 | |
| 632 | Ubiquitination | PFKSDPFKGADPFKG CCCCCCCCCCCCCCC | 59.59 | 21890473 | |
| 632 | Ubiquitination | PFKSDPFKGADPFKG CCCCCCCCCCCCCCC | 59.59 | 21890473 | |
| 632 | Ubiquitination | PFKSDPFKGADPFKG CCCCCCCCCCCCCCC | 59.59 | 21890473 | |
| 632 (in isoform 2) | Ubiquitination | - | 59.59 | - | |
| 638 | Ubiquitination | FKGADPFKGDPFQND CCCCCCCCCCCCCCC | 68.72 | 21890473 | |
| 638 | Ubiquitination | FKGADPFKGDPFQND CCCCCCCCCCCCCCC | 68.72 | 21890473 | |
| 638 | Ubiquitination | FKGADPFKGDPFQND CCCCCCCCCCCCCCC | 68.72 | 21890473 | |
| 652 | Phosphorylation | DPFAEQQTTSTDPFG CCCHHCCCCCCCCCC | 23.55 | 28348404 | |
| 653 | Phosphorylation | PFAEQQTTSTDPFGG CCHHCCCCCCCCCCC | 25.87 | 28348404 | |
| 654 | Phosphorylation | FAEQQTTSTDPFGGD CHHCCCCCCCCCCCC | 33.91 | 28348404 | |
| 655 | Phosphorylation | AEQQTTSTDPFGGDP HHCCCCCCCCCCCCC | 45.67 | 28348404 | |
| 664 | Ubiquitination | PFGGDPFKESDPFRG CCCCCCCCCCCCCCC | 62.79 | 21906983 | |
| 666 | Phosphorylation | GGDPFKESDPFRGSA CCCCCCCCCCCCCCC | 51.69 | 23663014 | |
| 672 | Phosphorylation | ESDPFRGSATDDFFK CCCCCCCCCCHHHHH | 24.60 | 25159151 | |
| 672 (in isoform 2) | Phosphorylation | - | 24.60 | 27251275 | |
| 674 | Phosphorylation | DPFRGSATDDFFKKQ CCCCCCCCHHHHHHH | 37.49 | 23663014 | |
| 679 | Ubiquitination | SATDDFFKKQTKNDP CCCHHHHHHHHCCCC | 43.92 | 21890473 | |
| 679 | Ubiquitination | SATDDFFKKQTKNDP CCCHHHHHHHHCCCC | 43.92 | 21890473 | |
| 679 (in isoform 2) | Ubiquitination | - | 43.92 | - | |
| 680 | Ubiquitination | ATDDFFKKQTKNDPF CCHHHHHHHHCCCCC | 59.03 | - | |
| 680 (in isoform 2) | Ubiquitination | - | 59.03 | - | |
| 683 | Ubiquitination | DFFKKQTKNDPFTSD HHHHHHHCCCCCCCC | 57.78 | 21890473 | |
| 683 | Ubiquitination | DFFKKQTKNDPFTSD HHHHHHHCCCCCCCC | 57.78 | 21890473 | |
| 683 (in isoform 2) | Ubiquitination | - | 57.78 | - | |
| 688 | Phosphorylation | QTKNDPFTSDPFTKN HHCCCCCCCCCCCCC | 37.29 | 28348404 | |
| 689 | Phosphorylation | TKNDPFTSDPFTKNP HCCCCCCCCCCCCCC | 43.60 | 28348404 | |
| 689 (in isoform 2) | Phosphorylation | - | 43.60 | 27251275 | |
| 694 | Ubiquitination | FTSDPFTKNPSLPSK CCCCCCCCCCCCCCC | 68.21 | 21890473 | |
| 694 (in isoform 2) | Ubiquitination | - | 68.21 | - | |
| 697 | Phosphorylation | DPFTKNPSLPSKLDP CCCCCCCCCCCCCCC | 63.41 | 25849741 | |
| 697 (in isoform 2) | Phosphorylation | - | 63.41 | 27251275 | |
| 700 | Phosphorylation | TKNPSLPSKLDPFES CCCCCCCCCCCCCCC | 51.66 | 30576142 | |
| 701 | Ubiquitination | KNPSLPSKLDPFESS CCCCCCCCCCCCCCC | 55.77 | 21890473 | |
| 701 | Ubiquitination | KNPSLPSKLDPFESS CCCCCCCCCCCCCCC | 55.77 | 21890473 | |
| 701 | Ubiquitination | KNPSLPSKLDPFESS CCCCCCCCCCCCCCC | 55.77 | 21890473 | |
| 701 (in isoform 2) | Ubiquitination | - | 55.77 | - | |
| 707 | Phosphorylation | SKLDPFESSDPFSSS CCCCCCCCCCCCCCC | 40.18 | 25159151 | |
| 707 (in isoform 2) | Phosphorylation | - | 40.18 | 27251275 | |
| 708 | Phosphorylation | KLDPFESSDPFSSSS CCCCCCCCCCCCCCC | 41.95 | 25159151 | |
| 712 | Phosphorylation | FESSDPFSSSSVSSK CCCCCCCCCCCCCCC | 34.40 | 28450419 | |
| 713 | Phosphorylation | ESSDPFSSSSVSSKG CCCCCCCCCCCCCCC | 27.32 | 30108239 | |
| 714 | Phosphorylation | SSDPFSSSSVSSKGS CCCCCCCCCCCCCCC | 33.29 | 25159151 | |
| 714 (in isoform 2) | Phosphorylation | - | 33.29 | 27251275 | |
| 715 | Phosphorylation | SDPFSSSSVSSKGSD CCCCCCCCCCCCCCC | 28.15 | 28450419 | |
| 717 | Phosphorylation | PFSSSSVSSKGSDPF CCCCCCCCCCCCCCC | 28.42 | 30278072 | |
| 717 (in isoform 2) | Phosphorylation | - | 28.42 | 27251275 | |
| 718 | Phosphorylation | FSSSSVSSKGSDPFG CCCCCCCCCCCCCCC | 38.59 | 30108239 | |
| 719 | Ubiquitination | SSSSVSSKGSDPFGT CCCCCCCCCCCCCCC | 55.73 | - | |
| 732 | Phosphorylation | GTLDPFGSGSFNSAE CCCCCCCCCCCCCCC | 31.48 | 26657352 | |
| 734 | Phosphorylation | LDPFGSGSFNSAEGF CCCCCCCCCCCCCCC | 23.97 | 28270605 | |
| 734 (in isoform 2) | Phosphorylation | - | 23.97 | 27251275 | |
| 737 | Phosphorylation | FGSGSFNSAEGFADF CCCCCCCCCCCCCCH | 26.20 | 28270605 | |
| 745 | Phosphorylation | AEGFADFSQMSKPPP CCCCCCHHHCCCCCC | 26.06 | 28270605 | |
| 748 | Phosphorylation | FADFSQMSKPPPSGP CCCHHHCCCCCCCCC | 34.08 | 28270605 | |
| 772 | Phosphorylation | FSDDPFKSKQDTPAL CCCCCCCCCCCCCCC | 35.61 | 23312004 | |
| 776 | Phosphorylation | PFKSKQDTPALPPKK CCCCCCCCCCCCCCC | 14.15 | 28348404 | |
| 782 | Acetylation | DTPALPPKKPAPPRP CCCCCCCCCCCCCCC | 70.24 | 7674313 | |
| 783 | Acetylation | TPALPPKKPAPPRPK CCCCCCCCCCCCCCC | 52.78 | 7674325 | |
| 793 | Phosphorylation | PPRPKPPSGKSTPVS CCCCCCCCCCCCCHH | 68.34 | 30278072 | |
| 793 (in isoform 2) | Phosphorylation | - | 68.34 | 27251275 | |
| 796 | Phosphorylation | PKPPSGKSTPVSQLG CCCCCCCCCCHHHCC | 41.28 | 30206219 | |
| 796 (in isoform 2) | Phosphorylation | - | 41.28 | 27251275 | |
| 797 | Phosphorylation | KPPSGKSTPVSQLGS CCCCCCCCCHHHCCC | 31.06 | 21082442 | |
| 800 | Phosphorylation | SGKSTPVSQLGSADF CCCCCCHHHCCCCCC | 22.38 | 22199227 | |
| 804 | Phosphorylation | TPVSQLGSADFPEAP CCHHHCCCCCCCCCC | 33.00 | 28464451 | |
| 821 | Phosphorylation | FQPLGADSGDPFQSK CCCCCCCCCCCCCCC | 44.56 | 26074081 | |
| 827 | Phosphorylation | DSGDPFQSKKGFGDP CCCCCCCCCCCCCCC | 36.39 | 26074081 | |
| 828 | Ubiquitination | SGDPFQSKKGFGDPF CCCCCCCCCCCCCCC | 46.24 | 21890473 | |
| 828 | Ubiquitination | SGDPFQSKKGFGDPF CCCCCCCCCCCCCCC | 46.24 | 21890473 | |
| 828 (in isoform 2) | Ubiquitination | - | 46.24 | - | |
| 829 | Ubiquitination | GDPFQSKKGFGDPFS CCCCCCCCCCCCCCC | 65.79 | 21890473 | |
| 829 | Ubiquitination | GDPFQSKKGFGDPFS CCCCCCCCCCCCCCC | 65.79 | 21890473 | |
| 829 (in isoform 2) | Ubiquitination | - | 65.79 | - | |
| 838 | Ubiquitination | FGDPFSGKDPFVPSS CCCCCCCCCCCCCCH | 62.11 | 21890473 | |
| 838 | Ubiquitination | FGDPFSGKDPFVPSS CCCCCCCCCCCCCCH | 62.11 | 21890473 | |
| 838 (in isoform 2) | Ubiquitination | - | 62.11 | - | |
| 844 | Phosphorylation | GKDPFVPSSAAKPSK CCCCCCCCHHCCCCC | 27.57 | 28555341 | |
| 845 | Phosphorylation | KDPFVPSSAAKPSKA CCCCCCCHHCCCCCC | 26.61 | 25159151 | |
| 848 | Ubiquitination | FVPSSAAKPSKASAS CCCCHHCCCCCCCCC | 49.92 | 21890473 | |
| 848 | Ubiquitination | FVPSSAAKPSKASAS CCCCHHCCCCCCCCC | 49.92 | 21890473 | |
| 848 (in isoform 2) | Ubiquitination | - | 49.92 | - | |
| 851 | Ubiquitination | SSAAKPSKASASGFA CHHCCCCCCCCCCCC | 55.69 | - | |
| 851 (in isoform 2) | Ubiquitination | - | 55.69 | - | |
| 853 (in isoform 2) | Phosphorylation | - | 27.06 | 27251275 | |
| 855 (in isoform 2) | Phosphorylation | - | 31.76 | 27251275 | |
| 861 (in isoform 2) | Phosphorylation | - | 28.85 | 27251275 | |
| 862 (in isoform 2) | Phosphorylation | - | 21.98 | 27251275 | |
| 904 | Ubiquitination | ----------------------------------------------- ----------------------------------------------- | 21890473 | ||
| 904 (in isoform 2) | Ubiquitination | - | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EP15R_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EP15R_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EP15R_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| AGFG1_HUMAN | AGFG1 | genetic | 10613896 | |
| UBQL1_HUMAN | UBQLN1 | physical | 16159959 | |
| BIRC6_HUMAN | BIRC6 | physical | 22863883 | |
| CND3_HUMAN | NCAPG | physical | 22863883 | |
| PRP4_HUMAN | PRPF4 | physical | 22863883 | |
| ZZEF1_HUMAN | ZZEF1 | physical | 22863883 | |
| AGFG2_HUMAN | AGFG2 | genetic | 10613896 | |
| DCAF7_HUMAN | DCAF7 | physical | 27173435 | |
| UBP15_HUMAN | USP15 | physical | 27173435 | |
| JIP4_HUMAN | SPAG9 | physical | 27173435 | |
| MCM2_HUMAN | MCM2 | physical | 27173435 | |
| MCM4_HUMAN | MCM4 | physical | 27173435 | |
| MCM6_HUMAN | MCM6 | physical | 27173435 | |
| NS1BP_HUMAN | IVNS1ABP | physical | 27173435 | |
| SMC1A_HUMAN | SMC1A | physical | 27173435 | |
| GAPD1_HUMAN | GAPVD1 | physical | 27173435 | |
| ANK3_HUMAN | ANK3 | physical | 27173435 | |
| SBNO1_HUMAN | SBNO1 | physical | 27173435 | |
| SMC3_HUMAN | SMC3 | physical | 27173435 | |
| CD11A_HUMAN | CDK11A | physical | 27173435 | |
| SOX4_HUMAN | SOX4 | physical | 27173435 | |
| HSF1_HUMAN | HSF1 | physical | 27173435 | |
| PLK1_HUMAN | PLK1 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-229; SER-238 AND SER-255, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; SER-255; SER-560;THR-577 AND THR-797, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-229; SER-238 AND SER-255, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY. | |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-366; SER-371 ANDSER-374, AND MASS SPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108 AND SER-793, ANDMASS SPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229, AND MASSSPECTROMETRY. | |
| "Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry."; Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.; Anal. Chem. 76:2763-2772(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241; SER-244 ANDSER-255, AND MASS SPECTROMETRY. | |